Is ucb-biopharma.com.br Safe? Security Analysis for UCB Biopharma Ltda.
https://ucb-biopharma.com.brCheck if ucb-biopharma.com.br is a scam or legitimate. Free security scan and reviews.
Below Healthcare avg (65)
10,000+
Domains scanned
500+
Security teams trust us
EveryPay
Secure checkout
Instant
Reports delivered
Get the professional PDF report for ucb-biopharma.com.br
Export this security analysis as a professional PDF document, receive it via email, and access marketing intelligence data including contact emails and phone numbers. One-time purchase for lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
AI Summary
UCB Biopharma Ltda. is a regional branch of the global biopharmaceutical company UCB S.A., Belgium, specializing in innovative medicines for immunology and neurology. The website serves patients, healthcare professionals, and partners in Brazil, offering detailed information about therapeutic areas, patient support programs, and pharmacovigilance. The company positions itself as a trusted healthcare provider with a strong focus on improving patient quality of life through science-driven solutions. Technically, the website is built on Drupal CMS, hosted on Microsoft Azure infrastructure, and integrates modern analytics and cookie consent tools, reflecting a mature digital presence. Security posture is solid with HTTPS enforced and cookie consent mechanisms in place, though explicit security headers could be improved. Privacy compliance is well addressed with comprehensive privacy and cookie policies in Portuguese, aligned with GDPR principles. Overall, the site demonstrates good professionalism, trustworthiness, and user experience, supporting UCB's market position as a leading specialty pharma company in Brazil.
Detected Technologies
10 urgent findings need attention
10 high
- + 2 more findings in the full report below
Keep ucb-biopharma.com.br under constant watch
Guard tracks your live infrastructure daily: certificate expiry, DNS & mail authentication drift, uptime changes, subdomain inventory, and unexpected tracker or content shifts. A full timeline captures every diff so you can prove remediation and spot regressions instantly.
Security drift alerts
Risk score drops, new high-severity issues, and header hardening gaps
Compliance watch
GDPR / NIS2 posture changes with governance evidence snapshots
Infrastructure surface
Unexpected open services, SSL expiry, DNS & email authentication changes
Content & tracker intelligence
Marketing tech shifts, analytics drift, and AI recommendation updates
Cancel anytime. Alerts sent to the contacts you choose. Unlock the full report to view historical timelines and alerts.
Security Headers
4 findings
65/100
GDPR Compliance
2 findings
65/100
NIS2 Compliance
9 findings
2/100
Email Security
4 findings
75/100
🧠AI Business Intelligence
Technology stack, business insights, and market analysis powered by AI.
Business Intelligence
Market & Strategic Analysis
The company operates in the healthcare sector focusing on specialty pharmaceuticals in immunology and neurology. Its business model includes research, development, and commercialization of innovative medicines, supported by patient assistance programs to enhance treatment adherence and outcomes. The website reflects a large enterprise with global parentage and local market adaptation. The presence of multiple country-specific domains and patient support initiatives indicates a broad partnership ecosystem and strategic market penetration. The company leverages digital channels and social media to engage stakeholders and maintain brand visibility. No direct revenue streams or financial data are disclosed on the site, but the comprehensive content and support programs suggest a customer-centric approach and investment in patient care.
Security Posture Analysis
Comprehensive Security Assessment
The website demonstrates a good security maturity level with HTTPS enabled and a cookie consent mechanism powered by OneTrust, ensuring user privacy and compliance. No exposed sensitive data or vulnerable libraries were detected in the HTML content. However, explicit security headers such as X-Frame-Options and X-Content-Type-Options are not clearly present and should be verified. There is no public security policy or incident response contact information, which could be improved to enhance transparency and readiness. The use of reputable third-party analytics and consent tools indicates a controlled data collection environment. Overall, the security posture is solid but could benefit from enhanced header configurations and published security policies.
Strategic Recommendations
Priority Actions for Security Improvement
Implement and verify standard security headers (X-Frame-Options, X-Content-Type-Options) to mitigate clickjacking and MIME sniffing risks.
✨Observations
AI-powered comprehensive website and business analysis.
AI-Enhanced Website Analysis
Business Insights
UCB Biopharma Ltda.
UCB Biopharma Brasil offers innovative medicines in immunology and neurology, aiming to improve quality of life for patients with serious diseases worldwide.
good
consistent
Technical Stack
moderate
good
good
good
Security Assessment
- HTTPS enforced
- Cookie consent mechanism implemented
- No exposed sensitive data in HTML
- Use of security-focused scripts
Analytics & Tracking
Advertising & Marketing
Website Quality Assessment
Key Observations
Website is fully accessible with no blocking or WAF challenge.
Get this report delivered to your inbox
Receive a summary of the ucb-biopharma.com.br security findings by email. Quick and easy to share with decision makers.
🛡️Security Headers
HTTP security headers analysis and recommendations.
Security Headers
HTTP security headers analysis
Missing Content-Security-Policy header
HIGHControls resources the browser is allowed to load
Missing Referrer-Policy header
LOWControls referrer information sent with requests
Missing Permissions-Policy header
MEDIUMControls browser features and APIs
Sensitive data may be cached
LOWCache-Control header should include "no-store" for sensitive pages
👤GDPR Compliance
Privacy and data protection assessment under GDPR regulations.
GDPR Compliance
Privacy and data protection assessment
No Privacy Policy found
HIGHGDPR requires a clear and accessible privacy policy
Third-party services without privacy policy
HIGHDetected services: Google Analytics, Facebook, Twitter, LinkedIn, YouTube
GDPR Compliance Analysis
🛡️NIS2 Compliance
Network & Information Security Directive compliance assessment.
NIS2 Compliance
Network & Information Security Directive
No information security framework found
HIGHNIS2 requires documented cybersecurity and information security measures
No vulnerability disclosure policy
MEDIUMNIS2 encourages coordinated vulnerability disclosure
No security policy documentation found
HIGHNIS2 requires documented cybersecurity governance and risk management
No incident response procedures found
HIGHNIS2 requires documented incident response and business continuity plans
No business continuity planning found
MEDIUMNIS2 emphasizes operational resilience and business continuity
No security contact information
HIGHNIS2 requires clear incident reporting channels
No vulnerability reporting mechanism
MEDIUMClear vulnerability reporting supports coordinated disclosure
No NIS2 reference found
LOWConsider explicitly mentioning NIS2 compliance efforts
Critical sector without clear security compliance
HIGHDetected sectors: energy, transport, health, digital
Need this report as a PDF?
Download the complete ucb-biopharma.com.br security analysis as a professional PDF. Share it with your team, clients, or stakeholders.
📧Email Security
SPF, DKIM, and DMARC validation and email security assessment.
Email Security
SPF, DKIM, and DMARC validation
DMARC not enforcing
MEDIUMDMARC policy is set to "none"
No BIMI Record
LOWBIMI displays brand logos in email clients
No MTA-STS Policy
MEDIUMMTA-STS enforces TLS for email delivery
No TLS-RPT Record
LOWTLS-RPT provides reporting for email TLS issues
DKIM Selectors Found
DMARC Details
🏆SSL/TLS Security
Certificate validity and encryption analysis.
SSL/TLS Security
Certificate validity and encryption analysis
Weak Protocols Supported
HIGHServer supports weak protocols: TLSv1.1
OCSP Stapling Not Enabled
LOWOCSP stapling improves performance and privacy
Certificate Transparency Not Implemented
LOWCertificate is not logged in Certificate Transparency logs
SSL Certificate Expires Soon
HIGHSSL certificate expires in 16 days
Mixed Content Detected
MEDIUM6 resources loaded over insecure HTTP
Partial SSL/TLS Assessment
LOWCompleted 3 of 4 security checks due to time constraints
Protocol Support
OCSP Status
📊DNS Health
DNS configuration and security assessment.
DNS Health
DNS configuration and security assessment
DNSSEC Not Enabled
MEDIUMDNSSEC is not configured for this domain
CAA Records Not Configured
LOWCertificate Authority Authorization (CAA) records not found
Domain Transfer Lock Not Enabled
MEDIUMDomain can be transferred without authorization
Domain Delete Lock Not Enabled
LOWDomain can be deleted without additional verification
DMARC Policy Set to None
LOWDMARC is configured but not enforcing any policy
Domain Registration Details
- •No domain protection locks enabled
DNS Records
DNSSEC Status
DNS Performance
⚡Network Security
Port scanning and network exposure analysis.
Network Security
Port scanning and network exposure analysis
Good Network Security Posture
LOWNo unnecessary services detected on common risky ports
How does ucb-biopharma.com.br compare?
See how ucb-biopharma.com.br stacks up against similar websites in the same industry.
🔧Technical Analysis
Detailed technical findings and analysis from AI assessment.
Technical Analysis
Comprehensive security assessment findings
Additional Findings
Download the ucb-biopharma.com.br report as PDF
Get the complete analysis in a shareable PDF format, delivered instantly to your email with lifetime access.
PDF Report & Export
PDF download, email delivery, unlock code
Marketing Intelligence
Contact emails, phone numbers & warm leads
Plan Comparison
| Feature | PDF Report | Marketing+ |
|---|---|---|
| Full security analysis | ||
| Professional PDF export | ||
| Email delivery | ||
| Lifetime access + unlock code | ||
| Contact emails & phones | — | |
| Marketing outreach data | — |
Already purchased?
Order summary
Digital reports are delivered immediately after payment. By continuing you acknowledge the withdrawal waiver described in our Returns & Refunds policy.
Secure payments processed via EveryPay. Prices in EUR; Incl. 21% VAT.
SEQ SIA
Lastadijas 12 k-3, Riga, Latvia, LV-1050
Reg. No. 40203410806 • VAT LV40203410806
Support: guard@offseq.com • +371 2256 5353
Scan your own website
Liked the ucb-biopharma.com.br report? Run the same comprehensive security analysis on your domain — free, instant, and no sign-up required.
Or browse our directory of >10,000 scanned websites.
How did we do?
Your feedback directly shapes our roadmap. Rate the quality of this report, leave an optional comment, and let us know if you want our security specialists to follow up.
What others say about ucb-biopharma.com.br
Share your experience to help others make informed decisions. We verify every review by email and publish it once our moderation team approves it.
Community rating
—out of 5
0 reviews published